https://biolabsresearch.co/news/jama-viewpoint-argues-fda-advisory-committee-peptide-votes-threaten-the-drugBioLabs Researchen2026-10-27T06:22:44.705ZJAMA Viewpoint argues FDA advisory committee peptide votes threaten the drug approval process https://biolabsresearch.co/news/fda-peptide-compounding-plan-would-reportedly-require-purity-and-identityBioLabs Researchen2026-10-26T06:20:46.136ZFDA peptide compounding plan would reportedly require purity and identity certification and adverse-event reporting